ACR GUIDELINES Bundle (free trial)

Periop ACR

American College of Rheumatology GUIDELINES Apps brought to you free of charge courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/1512446

Contents of this Issue

Navigation

Page 4 of 7

Table 2. Medications to WITHHOLD Prior To Surgery** NOT-SEVERE SLE: WITHHOLD these medications 1 week prior to surgery Dosing Interval Recommended timing of surgery since last medication dose Mycophenolate mofetil Twice daily 1 week aer last dose Azathioprine Daily or twice daily 1 week aer last dose Cyclosporine Twice daily 1 week aer last dose Tacrolimus Twice daily (IV and PO) 1 week aer last dose Rituximab (Rituxan) Every 4–6 months Month 7 Belimumab IV (Benlysta) Monthly Week 5 Belimumab SQ (Benlysta) Weekly Week 2 Dosing intervals obtained om prescribing information provided online by pharmaceutical companies. Bold indicates recommendation that has changed since 2017. * Recommendation pertains to infection risk and does not account for risk of cardiac events or venous thromboembolism. ** For patients with RA, AS, PsA, or all SLE for whom anti-rheumatic therapy was held prior to undergoing TJA, restarting the anti-rheumatic therapy once the wound shows evidence of healing, any sutures/staples are out, there is no significant swelling, erythema or drainage, and there is no ongoing non-surgical site infection, which is typically about 14 days. † Drug added for 2022 update. (cont'd)

Articles in this issue

Archives of this issue

view archives of ACR GUIDELINES Bundle (free trial) - Periop ACR